Unterhuber M, Rauhe W, Sgobino P, Pescoller F, Manfrin M, Tomaino M
Department of Cardiology, Central Hospital of Bolzano, Italy.
Emergency Room, Central Hospital of Bolzano, Italy.
J Atr Fibrillation. 2016 Aug 31;9(2):1398. doi: 10.4022/jafib.1398. eCollection 2016 Aug-Sep.
Through a retrospective study concerning the experience of our center in patients affected by Neurally Mediated reflex Syncope (NMS) we wanted to verify not only the diagnostic yield of the Implantable Loop Recorder (ILR) but its possible placebo therapeutic effect. In the context of patients affected by a severe clinical presentation of NMS identified through a careful clinical evaluation, we selected those who followed a diagnostic iter using the ILR. We analysed 84 patients (39 male and 45 female, mean age 71 years), during the period 2009-2013. 34 patients (40.5%) had no recurrences after a mean follow-up (FU) of 35 months, among these 17 concluded a FU of 4 years. 50 patients (59.5%) had recurrences and a specific diagnosis after an average period of 7 months. We found an important number of patients who showed a disappearance of syncope during an observation period of 2-3 and 4 years. At first glance this results could be explained considering the possible placebo therapeutic effect of ILR.
通过一项关于我们中心神经介导反射性晕厥(NMS)患者治疗经验的回顾性研究,我们不仅想验证植入式循环记录仪(ILR)的诊断效率,还想验证其可能的安慰剂治疗效果。在通过仔细的临床评估确定为患有严重NMS临床表现的患者中,我们选择了那些使用ILR进行诊断流程的患者。我们分析了2009年至2013年期间的84例患者(39例男性和45例女性,平均年龄71岁)。34例患者(40.5%)在平均随访(FU)35个月后未复发,其中17例完成了4年的随访。50例患者(59.5%)在平均7个月的时间后复发并得到了明确诊断。我们发现有相当数量的患者在2至3年和4年的观察期内晕厥消失。乍一看,考虑到ILR可能的安慰剂治疗效果,这一结果是可以解释的。